We are live on ! Find out more
MSAC

Medicus Sciences Acquisition Corp. Class A Ordinary Share

Delisted

MSAC was delisted on the 17th of February, 2023.

46 hedge funds and large institutions have $77.5M invested in Medicus Sciences Acquisition Corp. Class A Ordinary Share in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

9% more capital invested

Capital invested by funds: $71.4M → $77.5M (+$6.11M)

5% more funds holding

Funds holding: 4446 (+2)

Holders
46
Holders Change
+2
Holders Change %
+4.55%
% of All Funds
0.81%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
5
Increased
12
Reduced
5
Closed
3
Calls
$38K
Puts
Net Calls
+$38K
Net Calls Change
-$12K
Name Holding Trade Value Shares
Change
Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$7.7M
TP
2
Third Point
New York
$7.7M
HM
3
HealthCor Management
New York
$7.25M
SCM
4
Saba Capital Management
New York
$5.79M +$3.46M +359,159 +153%
APM
5
Avidity Partners Management
Texas
$5.07M
GCL
6
Glazer Capital LLC
New York
$4.42M -$2.94K -305 -0.1%
KC
7
Kepos Capital
New York
$3.9M -$1.2M -125,000 -24%
AAA
8
Affinity Asset Advisors
New York
$2.92M
CCM
9
Consonance Capital Management
New York
$2.92M
KCM
10
Kingdon Capital Management
New York
$2.92M
RI
11
RTW Investments
New York
$2.92M
Hudson Bay Capital Management
12
Hudson Bay Capital Management
Connecticut
$2.44M
WCMNY
13
Westchester Capital Management (New York)
New York
$2.33M
DMK
14
David M. Knott
$1.95M +$1.93M +200,000 New
SMA
15
Sage Mountain Advisors
Georgia
$1.75M +$80.2K +8,330 +5%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$1.68M +$1.66M +172,065 New
WC
17
Wealthspring Capital
New York
$1.38M +$231K +23,960 +20%
KKRC
18
Kohlberg Kravis Roberts & Co
New York
$1.1M +$1.09M +113,117 New
SCM
19
Silverarc Capital Management
Massachusetts
$1.07M -$2.54M -263,235 -71%
PCM
20
Prelude Capital Management
New York
$1.01M +$498K +51,700 +100%
JAM
21
JW Asset Management
Florida
$975K
PC
22
Periscope Capital
Ontario, Canada
$975K
AA
23
AQR Arbitrage
Connecticut
$962K +$419K +43,490 +79%
CCA
24
Cruiser Capital Advisors
Connecticut
$901K
Millennium Management
25
Millennium Management
New York
$557K

MSAC Hedge Fund Activity: Q3 2021 in Review

46 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) for Q3 2021, worth a combined $77.5M — up 8.5% from $71.4M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MSAC positions and 3 closed out — a net gain of 2 holders — while 12 added to existing stakes and 5 trimmed.

The largest buyer was Saba Capital Management, adding an estimated $3.46M. The largest seller was J. Goldman & Co, exiting entirely with an estimated $2.89M sold.

  • 46 institutional investors held Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) as of Q3 2021, up from 44 in Q2 2021.
  • Funds reported $77.5M of Medicus Sciences Acquisition Corp. Class A Ordinary Share stock for Q3 2021, up 8.5% quarter-over-quarter.
  • 5 funds opened new Medicus Sciences Acquisition Corp. Class A Ordinary Share positions in Q3 2021 and 3 closed out, a net change of +2 holders.
  • The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share buyer in Q3 2021 was Saba Capital Management, an estimated $3.46M added.
  • The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share seller in Q3 2021 was J. Goldman & Co, an estimated $2.89M sold.

Based on aggregated 13F filings for Q3 2021.